Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Seminoma Retroperitoneal Relapse 23 Years After Surgery.
Crocetti S, Tassone L, Torniai M, Pierantoni C, Burattini L, Mandolesi A, Di Benedetto M, Mantello G, Scarpelli M, Berardi R. Crocetti S, et al. Among authors: pierantoni c. Oncol Ther. 2021 Jun;9(1):239-245. doi: 10.1007/s40487-021-00141-9. Epub 2021 Feb 19. Oncol Ther. 2021. PMID: 33606194 Free PMC article.
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S. Scartozzi M, et al. Among authors: pierantoni c. J Clin Oncol. 2007 Sep 1;25(25):3930-5. doi: 10.1200/JCO.2007.11.5022. J Clin Oncol. 2007. PMID: 17761976
Pancreatic cancer: progress in cancer therapy.
Pierantoni C, Pagliacci A, Scartozzi M, Berardi R, Bianconi M, Cascinu S. Pierantoni C, et al. Crit Rev Oncol Hematol. 2008 Jul;67(1):27-38. doi: 10.1016/j.critrevonc.2008.01.009. Epub 2008 Mar 19. Crit Rev Oncol Hematol. 2008. PMID: 18356073 Review.
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
Scartozzi M, Bearzi I, Mandolesi A, Pierantoni C, Loupakis F, Zaniboni A, Negri F, Quadri A, Zorzi F, Galizia E, Berardi R, Biscotti T, Labianca R, Masi G, Falcone A, Cascinu S. Scartozzi M, et al. Among authors: pierantoni c. BMC Cancer. 2009 Aug 27;9:303. doi: 10.1186/1471-2407-9-303. BMC Cancer. 2009. PMID: 19712476 Free PMC article.
Pre-operative treatment modalities in gastric cancer patients.
Scartozzi M, Berardi R, Pierantoni C, Cascinu S. Scartozzi M, et al. Among authors: pierantoni c. Ann Oncol. 2005 May;16 Suppl 4:iv106-109. doi: 10.1093/annonc/mdi918. Ann Oncol. 2005. PMID: 15923409 Free article. Review. No abstract available.
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.
Cascinu S, Scartozzi M, Carbonari G, Pierantoni C, Verdecchia L, Mariani C, Squadroni M, Antognoli S, Silva RR, Giampieri R, Berardi R. Cascinu S, et al. Among authors: pierantoni c. Am J Clin Oncol. 2007 Oct;30(5):526-30. doi: 10.1097/COC.0b013e318054675c. Am J Clin Oncol. 2007. PMID: 17921715 Clinical Trial.
57 results